nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0334	0.319	CbGbCtD
Rufinamide—CYP2E1—Etoposide—uterine cancer	0.0326	0.312	CbGbCtD
Rufinamide—CYP3A4—Progesterone—uterine cancer	0.0221	0.211	CbGbCtD
Rufinamide—CYP3A4—Etoposide—uterine cancer	0.00989	0.0944	CbGbCtD
Rufinamide—CYP3A4—Doxorubicin—uterine cancer	0.00675	0.0644	CbGbCtD
Rufinamide—SCN7A—myometrium—uterine cancer	0.0045	0.122	CbGeAlD
Rufinamide—GRM5—female reproductive system—uterine cancer	0.00415	0.112	CbGeAlD
Rufinamide—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.00332	0.00453	CcSEcCtD
Rufinamide—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.0033	0.0045	CcSEcCtD
Rufinamide—Mental disorder—Progesterone—uterine cancer	0.00325	0.00444	CcSEcCtD
Rufinamide—Malnutrition—Progesterone—uterine cancer	0.00323	0.00441	CcSEcCtD
Rufinamide—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.00314	0.00429	CcSEcCtD
Rufinamide—Back pain—Progesterone—uterine cancer	0.00312	0.00426	CcSEcCtD
Rufinamide—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00312	0.00426	CcSEcCtD
Rufinamide—Neutropenia—Dactinomycin—uterine cancer	0.00306	0.00418	CcSEcCtD
Rufinamide—Vision blurred—Progesterone—uterine cancer	0.00304	0.00415	CcSEcCtD
Rufinamide—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00304	0.00414	CcSEcCtD
Rufinamide—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00303	0.00414	CcSEcCtD
Rufinamide—Tremor—Progesterone—uterine cancer	0.00303	0.00413	CcSEcCtD
Rufinamide—Anaemia—Progesterone—uterine cancer	0.00299	0.00407	CcSEcCtD
Rufinamide—Nystagmus—Epirubicin—uterine cancer	0.00297	0.00405	CcSEcCtD
Rufinamide—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00295	0.00402	CcSEcCtD
Rufinamide—Pneumonia—Dactinomycin—uterine cancer	0.00294	0.00401	CcSEcCtD
Rufinamide—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00293	0.00399	CcSEcCtD
Rufinamide—Vertigo—Progesterone—uterine cancer	0.0029	0.00396	CcSEcCtD
Rufinamide—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00283	0.00386	CcSEcCtD
Rufinamide—Convulsion—Progesterone—uterine cancer	0.0028	0.00382	CcSEcCtD
Rufinamide—Nystagmus—Doxorubicin—uterine cancer	0.00274	0.00375	CcSEcCtD
Rufinamide—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00274	0.00374	CcSEcCtD
Rufinamide—Anxiety—Progesterone—uterine cancer	0.00274	0.00374	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00273	0.00373	CcSEcCtD
Rufinamide—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00271	0.00369	CcSEcCtD
Rufinamide—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00269	0.00367	CcSEcCtD
Rufinamide—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00263	0.00359	CcSEcCtD
Rufinamide—SCN7A—female reproductive system—uterine cancer	0.00262	0.0709	CbGeAlD
Rufinamide—Infection—Progesterone—uterine cancer	0.00262	0.00357	CcSEcCtD
Rufinamide—Nervous system disorder—Progesterone—uterine cancer	0.00259	0.00353	CcSEcCtD
Rufinamide—Skin disorder—Progesterone—uterine cancer	0.00256	0.00349	CcSEcCtD
Rufinamide—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00254	0.00346	CcSEcCtD
Rufinamide—Anorexia—Progesterone—uterine cancer	0.00251	0.00343	CcSEcCtD
Rufinamide—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00248	0.00339	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00247	0.00338	CcSEcCtD
Rufinamide—SCN7A—female gonad—uterine cancer	0.00239	0.0645	CbGeAlD
Rufinamide—Insomnia—Progesterone—uterine cancer	0.00238	0.00325	CcSEcCtD
Rufinamide—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00237	0.00324	CcSEcCtD
Rufinamide—Bone disorder—Epirubicin—uterine cancer	0.00235	0.0032	CcSEcCtD
Rufinamide—Somnolence—Progesterone—uterine cancer	0.00234	0.0032	CcSEcCtD
Rufinamide—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00234	0.0032	CcSEcCtD
Rufinamide—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00234	0.00319	CcSEcCtD
Rufinamide—Dyspepsia—Progesterone—uterine cancer	0.00232	0.00317	CcSEcCtD
Rufinamide—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00232	0.00317	CcSEcCtD
Rufinamide—Decreased appetite—Progesterone—uterine cancer	0.00229	0.00313	CcSEcCtD
Rufinamide—SCN4A—renal system—uterine cancer	0.00229	0.0619	CbGeAlD
Rufinamide—Nocturia—Epirubicin—uterine cancer	0.00228	0.00312	CcSEcCtD
Rufinamide—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00228	0.00311	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Progesterone—uterine cancer	0.00228	0.00311	CcSEcCtD
Rufinamide—Fatigue—Progesterone—uterine cancer	0.00227	0.0031	CcSEcCtD
Rufinamide—Constipation—Progesterone—uterine cancer	0.00225	0.00308	CcSEcCtD
Rufinamide—Neutropenia—Etoposide—uterine cancer	0.00222	0.00303	CcSEcCtD
Rufinamide—Gait disturbance—Epirubicin—uterine cancer	0.00217	0.00296	CcSEcCtD
Rufinamide—Bone disorder—Doxorubicin—uterine cancer	0.00217	0.00296	CcSEcCtD
Rufinamide—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00216	0.00295	CcSEcCtD
Rufinamide—Coordination abnormal—Epirubicin—uterine cancer	0.00216	0.00294	CcSEcCtD
Rufinamide—Pneumonia—Etoposide—uterine cancer	0.00213	0.0029	CcSEcCtD
Rufinamide—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00212	0.0029	CcSEcCtD
Rufinamide—Infestation—Etoposide—uterine cancer	0.00211	0.00289	CcSEcCtD
Rufinamide—Infestation NOS—Etoposide—uterine cancer	0.00211	0.00289	CcSEcCtD
Rufinamide—Nocturia—Doxorubicin—uterine cancer	0.00211	0.00288	CcSEcCtD
Rufinamide—Anaemia—Dactinomycin—uterine cancer	0.00211	0.00288	CcSEcCtD
Rufinamide—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.0021	0.00287	CcSEcCtD
Rufinamide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00208	0.00283	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.00281	CcSEcCtD
Rufinamide—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.00281	CcSEcCtD
Rufinamide—Leukopenia—Dactinomycin—uterine cancer	0.00204	0.00279	CcSEcCtD
Rufinamide—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00204	0.00279	CcSEcCtD
Rufinamide—Gait disturbance—Doxorubicin—uterine cancer	0.00201	0.00274	CcSEcCtD
Rufinamide—Hepatobiliary disease—Etoposide—uterine cancer	0.002	0.00273	CcSEcCtD
Rufinamide—Coordination abnormal—Doxorubicin—uterine cancer	0.002	0.00272	CcSEcCtD
Rufinamide—Hypersensitivity—Progesterone—uterine cancer	0.00194	0.00265	CcSEcCtD
Rufinamide—Asthenia—Progesterone—uterine cancer	0.00189	0.00258	CcSEcCtD
Rufinamide—Urinary tract disorder—Etoposide—uterine cancer	0.00187	0.00256	CcSEcCtD
Rufinamide—Pruritus—Progesterone—uterine cancer	0.00187	0.00255	CcSEcCtD
Rufinamide—Urethral disorder—Etoposide—uterine cancer	0.00186	0.00254	CcSEcCtD
Rufinamide—Infection—Dactinomycin—uterine cancer	0.00185	0.00253	CcSEcCtD
Rufinamide—Thrombocytopenia—Dactinomycin—uterine cancer	0.00182	0.00249	CcSEcCtD
Rufinamide—SCN3A—decidua—uterine cancer	0.00181	0.049	CbGeAlD
Rufinamide—Diarrhoea—Progesterone—uterine cancer	0.0018	0.00246	CcSEcCtD
Rufinamide—Lymphadenopathy—Epirubicin—uterine cancer	0.0018	0.00246	CcSEcCtD
Rufinamide—SCN3A—renal system—uterine cancer	0.00178	0.0481	CbGeAlD
Rufinamide—Anorexia—Dactinomycin—uterine cancer	0.00178	0.00242	CcSEcCtD
Rufinamide—Eye disorder—Etoposide—uterine cancer	0.00177	0.00242	CcSEcCtD
Rufinamide—Cardiac disorder—Etoposide—uterine cancer	0.00176	0.0024	CcSEcCtD
Rufinamide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.0024	CcSEcCtD
Rufinamide—Dizziness—Progesterone—uterine cancer	0.00174	0.00238	CcSEcCtD
Rufinamide—Immune system disorder—Etoposide—uterine cancer	0.00171	0.00234	CcSEcCtD
Rufinamide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00234	CcSEcCtD
Rufinamide—Mediastinal disorder—Etoposide—uterine cancer	0.00171	0.00233	CcSEcCtD
Rufinamide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.00231	CcSEcCtD
Rufinamide—Vomiting—Progesterone—uterine cancer	0.00168	0.00229	CcSEcCtD
Rufinamide—Lymphadenopathy—Doxorubicin—uterine cancer	0.00167	0.00228	CcSEcCtD
Rufinamide—Rash—Progesterone—uterine cancer	0.00166	0.00227	CcSEcCtD
Rufinamide—Dermatitis—Progesterone—uterine cancer	0.00166	0.00227	CcSEcCtD
Rufinamide—Headache—Progesterone—uterine cancer	0.00165	0.00225	CcSEcCtD
Rufinamide—Increased appetite—Epirubicin—uterine cancer	0.00164	0.00223	CcSEcCtD
Rufinamide—CES1—female reproductive system—uterine cancer	0.00164	0.0443	CbGeAlD
Rufinamide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.00223	CcSEcCtD
Rufinamide—Decreased appetite—Dactinomycin—uterine cancer	0.00162	0.00221	CcSEcCtD
Rufinamide—Fatigue—Dactinomycin—uterine cancer	0.00161	0.00219	CcSEcCtD
Rufinamide—Back pain—Etoposide—uterine cancer	0.0016	0.00218	CcSEcCtD
Rufinamide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00158	0.00216	CcSEcCtD
Rufinamide—Nausea—Progesterone—uterine cancer	0.00157	0.00214	CcSEcCtD
Rufinamide—Diplopia—Epirubicin—uterine cancer	0.00154	0.0021	CcSEcCtD
Rufinamide—SCN7A—lymph node—uterine cancer	0.00153	0.0415	CbGeAlD
Rufinamide—Anaemia—Etoposide—uterine cancer	0.00153	0.00208	CcSEcCtD
Rufinamide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00207	CcSEcCtD
Rufinamide—Increased appetite—Doxorubicin—uterine cancer	0.00151	0.00207	CcSEcCtD
Rufinamide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.00206	CcSEcCtD
Rufinamide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.00205	CcSEcCtD
Rufinamide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.00204	CcSEcCtD
Rufinamide—CES1—female gonad—uterine cancer	0.00149	0.0403	CbGeAlD
Rufinamide—Vertigo—Etoposide—uterine cancer	0.00148	0.00203	CcSEcCtD
Rufinamide—Leukopenia—Etoposide—uterine cancer	0.00148	0.00202	CcSEcCtD
Rufinamide—SCN2A—vagina—uterine cancer	0.00147	0.0397	CbGeAlD
Rufinamide—Ataxia—Epirubicin—uterine cancer	0.00145	0.00197	CcSEcCtD
Rufinamide—Convulsion—Etoposide—uterine cancer	0.00143	0.00195	CcSEcCtD
Rufinamide—SCN3A—female reproductive system—uterine cancer	0.00143	0.0386	CbGeAlD
Rufinamide—Diplopia—Doxorubicin—uterine cancer	0.00142	0.00194	CcSEcCtD
Rufinamide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00194	CcSEcCtD
Rufinamide—Abdominal pain upper—Epirubicin—uterine cancer	0.0014	0.00192	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.0014	0.00191	CcSEcCtD
Rufinamide—Breast disorder—Epirubicin—uterine cancer	0.00139	0.0019	CcSEcCtD
Rufinamide—Nasopharyngitis—Epirubicin—uterine cancer	0.00138	0.00188	CcSEcCtD
Rufinamide—Hypersensitivity—Dactinomycin—uterine cancer	0.00137	0.00187	CcSEcCtD
Rufinamide—Infection—Etoposide—uterine cancer	0.00134	0.00183	CcSEcCtD
Rufinamide—Ataxia—Doxorubicin—uterine cancer	0.00134	0.00183	CcSEcCtD
Rufinamide—Asthenia—Dactinomycin—uterine cancer	0.00134	0.00182	CcSEcCtD
Rufinamide—Influenza—Epirubicin—uterine cancer	0.00133	0.00181	CcSEcCtD
Rufinamide—Thrombocytopenia—Etoposide—uterine cancer	0.00132	0.0018	CcSEcCtD
Rufinamide—Skin disorder—Etoposide—uterine cancer	0.00131	0.00179	CcSEcCtD
Rufinamide—Abdominal pain upper—Doxorubicin—uterine cancer	0.0013	0.00177	CcSEcCtD
Rufinamide—SCN3A—vagina—uterine cancer	0.00129	0.0349	CbGeAlD
Rufinamide—Breast disorder—Doxorubicin—uterine cancer	0.00129	0.00175	CcSEcCtD
Rufinamide—SCN5A—vagina—uterine cancer	0.00129	0.0348	CbGeAlD
Rufinamide—Anorexia—Etoposide—uterine cancer	0.00129	0.00175	CcSEcCtD
Rufinamide—Bronchitis—Epirubicin—uterine cancer	0.00128	0.00174	CcSEcCtD
Rufinamide—Diarrhoea—Dactinomycin—uterine cancer	0.00127	0.00174	CcSEcCtD
Rufinamide—Nasopharyngitis—Doxorubicin—uterine cancer	0.00127	0.00174	CcSEcCtD
Rufinamide—Dysuria—Epirubicin—uterine cancer	0.00124	0.0017	CcSEcCtD
Rufinamide—Neutropenia—Epirubicin—uterine cancer	0.00124	0.0017	CcSEcCtD
Rufinamide—Influenza—Doxorubicin—uterine cancer	0.00123	0.00168	CcSEcCtD
Rufinamide—Pollakiuria—Epirubicin—uterine cancer	0.00123	0.00168	CcSEcCtD
Rufinamide—Weight decreased—Epirubicin—uterine cancer	0.0012	0.00164	CcSEcCtD
Rufinamide—SCN9A—lymph node—uterine cancer	0.0012	0.0325	CbGeAlD
Rufinamide—Somnolence—Etoposide—uterine cancer	0.0012	0.00164	CcSEcCtD
Rufinamide—Pneumonia—Epirubicin—uterine cancer	0.00119	0.00163	CcSEcCtD
Rufinamide—Infestation NOS—Epirubicin—uterine cancer	0.00119	0.00162	CcSEcCtD
Rufinamide—Infestation—Epirubicin—uterine cancer	0.00119	0.00162	CcSEcCtD
Rufinamide—Vomiting—Dactinomycin—uterine cancer	0.00118	0.00162	CcSEcCtD
Rufinamide—Bronchitis—Doxorubicin—uterine cancer	0.00118	0.00161	CcSEcCtD
Rufinamide—Rash—Dactinomycin—uterine cancer	0.00117	0.0016	CcSEcCtD
Rufinamide—Decreased appetite—Etoposide—uterine cancer	0.00117	0.0016	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Etoposide—uterine cancer	0.00116	0.00159	CcSEcCtD
Rufinamide—Fatigue—Etoposide—uterine cancer	0.00116	0.00159	CcSEcCtD
Rufinamide—Constipation—Etoposide—uterine cancer	0.00115	0.00157	CcSEcCtD
Rufinamide—Dysuria—Doxorubicin—uterine cancer	0.00115	0.00157	CcSEcCtD
Rufinamide—Neutropenia—Doxorubicin—uterine cancer	0.00115	0.00157	CcSEcCtD
Rufinamide—Pollakiuria—Doxorubicin—uterine cancer	0.00114	0.00155	CcSEcCtD
Rufinamide—Haematuria—Epirubicin—uterine cancer	0.00113	0.00154	CcSEcCtD
Rufinamide—Hepatobiliary disease—Epirubicin—uterine cancer	0.00112	0.00153	CcSEcCtD
Rufinamide—Epistaxis—Epirubicin—uterine cancer	0.00112	0.00153	CcSEcCtD
Rufinamide—Weight decreased—Doxorubicin—uterine cancer	0.00111	0.00152	CcSEcCtD
Rufinamide—Sinusitis—Epirubicin—uterine cancer	0.00111	0.00152	CcSEcCtD
Rufinamide—Nausea—Dactinomycin—uterine cancer	0.00111	0.00151	CcSEcCtD
Rufinamide—Pneumonia—Doxorubicin—uterine cancer	0.0011	0.00151	CcSEcCtD
Rufinamide—Infestation NOS—Doxorubicin—uterine cancer	0.0011	0.0015	CcSEcCtD
Rufinamide—Infestation—Doxorubicin—uterine cancer	0.0011	0.0015	CcSEcCtD
Rufinamide—Rhinitis—Epirubicin—uterine cancer	0.00107	0.00146	CcSEcCtD
Rufinamide—Urinary tract disorder—Epirubicin—uterine cancer	0.00105	0.00143	CcSEcCtD
Rufinamide—Haematuria—Doxorubicin—uterine cancer	0.00105	0.00143	CcSEcCtD
Rufinamide—Urethral disorder—Epirubicin—uterine cancer	0.00104	0.00142	CcSEcCtD
Rufinamide—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00104	0.00142	CcSEcCtD
Rufinamide—Epistaxis—Doxorubicin—uterine cancer	0.00103	0.00141	CcSEcCtD
Rufinamide—Sinusitis—Doxorubicin—uterine cancer	0.00103	0.0014	CcSEcCtD
Rufinamide—Eye disorder—Epirubicin—uterine cancer	0.000994	0.00136	CcSEcCtD
Rufinamide—Hypersensitivity—Etoposide—uterine cancer	0.000994	0.00136	CcSEcCtD
Rufinamide—Cardiac disorder—Epirubicin—uterine cancer	0.000987	0.00135	CcSEcCtD
Rufinamide—Rhinitis—Doxorubicin—uterine cancer	0.000987	0.00135	CcSEcCtD
Rufinamide—Urinary tract disorder—Doxorubicin—uterine cancer	0.000972	0.00133	CcSEcCtD
Rufinamide—Asthenia—Etoposide—uterine cancer	0.000968	0.00132	CcSEcCtD
Rufinamide—Urethral disorder—Doxorubicin—uterine cancer	0.000965	0.00132	CcSEcCtD
Rufinamide—Immune system disorder—Epirubicin—uterine cancer	0.000961	0.00131	CcSEcCtD
Rufinamide—Mediastinal disorder—Epirubicin—uterine cancer	0.000959	0.00131	CcSEcCtD
Rufinamide—CES1—lymph node—uterine cancer	0.000958	0.0259	CbGeAlD
Rufinamide—Pruritus—Etoposide—uterine cancer	0.000954	0.0013	CcSEcCtD
Rufinamide—Mental disorder—Epirubicin—uterine cancer	0.000932	0.00127	CcSEcCtD
Rufinamide—Malnutrition—Epirubicin—uterine cancer	0.000926	0.00126	CcSEcCtD
Rufinamide—Diarrhoea—Etoposide—uterine cancer	0.000923	0.00126	CcSEcCtD
Rufinamide—Eye disorder—Doxorubicin—uterine cancer	0.00092	0.00126	CcSEcCtD
Rufinamide—SCN10A—lymph node—uterine cancer	0.000915	0.0247	CbGeAlD
Rufinamide—Cardiac disorder—Doxorubicin—uterine cancer	0.000914	0.00125	CcSEcCtD
Rufinamide—Back pain—Epirubicin—uterine cancer	0.000896	0.00122	CcSEcCtD
Rufinamide—Dizziness—Etoposide—uterine cancer	0.000892	0.00122	CcSEcCtD
Rufinamide—Immune system disorder—Doxorubicin—uterine cancer	0.000889	0.00121	CcSEcCtD
Rufinamide—Mediastinal disorder—Doxorubicin—uterine cancer	0.000887	0.00121	CcSEcCtD
Rufinamide—Vision blurred—Epirubicin—uterine cancer	0.000873	0.00119	CcSEcCtD
Rufinamide—Mental disorder—Doxorubicin—uterine cancer	0.000862	0.00118	CcSEcCtD
Rufinamide—Vomiting—Etoposide—uterine cancer	0.000857	0.00117	CcSEcCtD
Rufinamide—Malnutrition—Doxorubicin—uterine cancer	0.000857	0.00117	CcSEcCtD
Rufinamide—Anaemia—Epirubicin—uterine cancer	0.000856	0.00117	CcSEcCtD
Rufinamide—Agitation—Epirubicin—uterine cancer	0.000851	0.00116	CcSEcCtD
Rufinamide—Rash—Etoposide—uterine cancer	0.00085	0.00116	CcSEcCtD
Rufinamide—Dermatitis—Etoposide—uterine cancer	0.000849	0.00116	CcSEcCtD
Rufinamide—Headache—Etoposide—uterine cancer	0.000845	0.00115	CcSEcCtD
Rufinamide—CYP2E1—renal system—uterine cancer	0.000841	0.0227	CbGeAlD
Rufinamide—SCN3A—lymph node—uterine cancer	0.000834	0.0226	CbGeAlD
Rufinamide—Vertigo—Epirubicin—uterine cancer	0.000832	0.00114	CcSEcCtD
Rufinamide—Leukopenia—Epirubicin—uterine cancer	0.000829	0.00113	CcSEcCtD
Rufinamide—Back pain—Doxorubicin—uterine cancer	0.000829	0.00113	CcSEcCtD
Rufinamide—Vision blurred—Doxorubicin—uterine cancer	0.000808	0.0011	CcSEcCtD
Rufinamide—Convulsion—Epirubicin—uterine cancer	0.000802	0.0011	CcSEcCtD
Rufinamide—Nausea—Etoposide—uterine cancer	0.000801	0.00109	CcSEcCtD
Rufinamide—Anaemia—Doxorubicin—uterine cancer	0.000792	0.00108	CcSEcCtD
Rufinamide—Agitation—Doxorubicin—uterine cancer	0.000788	0.00107	CcSEcCtD
Rufinamide—Anxiety—Epirubicin—uterine cancer	0.000786	0.00107	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000783	0.00107	CcSEcCtD
Rufinamide—Vertigo—Doxorubicin—uterine cancer	0.00077	0.00105	CcSEcCtD
Rufinamide—Leukopenia—Doxorubicin—uterine cancer	0.000767	0.00105	CcSEcCtD
Rufinamide—Infection—Epirubicin—uterine cancer	0.000751	0.00102	CcSEcCtD
Rufinamide—Convulsion—Doxorubicin—uterine cancer	0.000743	0.00101	CcSEcCtD
Rufinamide—Nervous system disorder—Epirubicin—uterine cancer	0.000741	0.00101	CcSEcCtD
Rufinamide—Thrombocytopenia—Epirubicin—uterine cancer	0.00074	0.00101	CcSEcCtD
Rufinamide—Skin disorder—Epirubicin—uterine cancer	0.000734	0.001	CcSEcCtD
Rufinamide—Anxiety—Doxorubicin—uterine cancer	0.000727	0.000992	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000725	0.000989	CcSEcCtD
Rufinamide—Anorexia—Epirubicin—uterine cancer	0.000721	0.000983	CcSEcCtD
Rufinamide—Infection—Doxorubicin—uterine cancer	0.000695	0.000948	CcSEcCtD
Rufinamide—Nervous system disorder—Doxorubicin—uterine cancer	0.000686	0.000936	CcSEcCtD
Rufinamide—Thrombocytopenia—Doxorubicin—uterine cancer	0.000685	0.000935	CcSEcCtD
Rufinamide—Insomnia—Epirubicin—uterine cancer	0.000684	0.000933	CcSEcCtD
Rufinamide—Skin disorder—Doxorubicin—uterine cancer	0.000679	0.000927	CcSEcCtD
Rufinamide—CYP3A4—renal system—uterine cancer	0.000676	0.0183	CbGeAlD
Rufinamide—CYP2E1—female reproductive system—uterine cancer	0.000673	0.0182	CbGeAlD
Rufinamide—Somnolence—Epirubicin—uterine cancer	0.000672	0.000917	CcSEcCtD
Rufinamide—Anorexia—Doxorubicin—uterine cancer	0.000667	0.00091	CcSEcCtD
Rufinamide—ALB—lymph node—uterine cancer	0.000666	0.018	CbGeAlD
Rufinamide—Dyspepsia—Epirubicin—uterine cancer	0.000665	0.000908	CcSEcCtD
Rufinamide—Decreased appetite—Epirubicin—uterine cancer	0.000657	0.000897	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000653	0.000891	CcSEcCtD
Rufinamide—Fatigue—Epirubicin—uterine cancer	0.000652	0.000889	CcSEcCtD
Rufinamide—Constipation—Epirubicin—uterine cancer	0.000646	0.000882	CcSEcCtD
Rufinamide—Insomnia—Doxorubicin—uterine cancer	0.000633	0.000863	CcSEcCtD
Rufinamide—Somnolence—Doxorubicin—uterine cancer	0.000622	0.000849	CcSEcCtD
Rufinamide—Dyspepsia—Doxorubicin—uterine cancer	0.000616	0.00084	CcSEcCtD
Rufinamide—Decreased appetite—Doxorubicin—uterine cancer	0.000608	0.00083	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000604	0.000824	CcSEcCtD
Rufinamide—Fatigue—Doxorubicin—uterine cancer	0.000603	0.000823	CcSEcCtD
Rufinamide—Constipation—Doxorubicin—uterine cancer	0.000598	0.000816	CcSEcCtD
Rufinamide—Hypersensitivity—Epirubicin—uterine cancer	0.000557	0.00076	CcSEcCtD
Rufinamide—Asthenia—Epirubicin—uterine cancer	0.000542	0.00074	CcSEcCtD
Rufinamide—CYP3A4—female reproductive system—uterine cancer	0.000542	0.0146	CbGeAlD
Rufinamide—Pruritus—Epirubicin—uterine cancer	0.000535	0.00073	CcSEcCtD
Rufinamide—Diarrhoea—Epirubicin—uterine cancer	0.000517	0.000706	CcSEcCtD
Rufinamide—Hypersensitivity—Doxorubicin—uterine cancer	0.000515	0.000703	CcSEcCtD
Rufinamide—Asthenia—Doxorubicin—uterine cancer	0.000502	0.000685	CcSEcCtD
Rufinamide—Dizziness—Epirubicin—uterine cancer	0.0005	0.000682	CcSEcCtD
Rufinamide—Pruritus—Doxorubicin—uterine cancer	0.000495	0.000675	CcSEcCtD
Rufinamide—Vomiting—Epirubicin—uterine cancer	0.000481	0.000656	CcSEcCtD
Rufinamide—Diarrhoea—Doxorubicin—uterine cancer	0.000479	0.000653	CcSEcCtD
Rufinamide—Rash—Epirubicin—uterine cancer	0.000477	0.00065	CcSEcCtD
Rufinamide—Dermatitis—Epirubicin—uterine cancer	0.000476	0.00065	CcSEcCtD
Rufinamide—Headache—Epirubicin—uterine cancer	0.000474	0.000646	CcSEcCtD
Rufinamide—Dizziness—Doxorubicin—uterine cancer	0.000463	0.000631	CcSEcCtD
Rufinamide—Nausea—Epirubicin—uterine cancer	0.000449	0.000613	CcSEcCtD
Rufinamide—Vomiting—Doxorubicin—uterine cancer	0.000445	0.000607	CcSEcCtD
Rufinamide—Rash—Doxorubicin—uterine cancer	0.000441	0.000602	CcSEcCtD
Rufinamide—Dermatitis—Doxorubicin—uterine cancer	0.000441	0.000601	CcSEcCtD
Rufinamide—Headache—Doxorubicin—uterine cancer	0.000438	0.000598	CcSEcCtD
Rufinamide—Nausea—Doxorubicin—uterine cancer	0.000415	0.000567	CcSEcCtD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000246	0.00196	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—ERBB2—uterine cancer	0.000245	0.00195	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—VEGFA—uterine cancer	0.000244	0.00195	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—CTNNB1—uterine cancer	0.000243	0.00193	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—FBXW7—uterine cancer	0.000242	0.00193	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—NRAS—uterine cancer	0.000241	0.00192	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—MET—uterine cancer	0.000239	0.00191	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—CYP19A1—uterine cancer	0.000237	0.00189	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—ERBB2—uterine cancer	0.000236	0.00188	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—ERBB2—uterine cancer	0.000236	0.00188	CbGpPWpGaD
Rufinamide—CYP2E1—Metapathway biotransformation—CYP19A1—uterine cancer	0.000234	0.00186	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—EP300—uterine cancer	0.000233	0.00186	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—MET—uterine cancer	0.00023	0.00183	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—MET—uterine cancer	0.00023	0.00183	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—ERBB2—uterine cancer	0.000227	0.00181	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—ERBB2—uterine cancer	0.000227	0.00181	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—KRAS—uterine cancer	0.000227	0.00181	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—ERBB2—uterine cancer	0.000226	0.0018	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—EP300—uterine cancer	0.000226	0.0018	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—MET—uterine cancer	0.000222	0.00177	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—MET—uterine cancer	0.000222	0.00177	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—VEGFA—uterine cancer	0.000221	0.00176	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—MET—uterine cancer	0.000218	0.00174	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—HRAS—uterine cancer	0.000216	0.00172	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—CTNNB1—uterine cancer	0.000216	0.00172	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—VEGFA—uterine cancer	0.000214	0.0017	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—STK11—uterine cancer	0.000211	0.00168	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—NRAS—uterine cancer	0.000211	0.00168	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—CCL2—uterine cancer	0.00021	0.00168	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—KRAS—uterine cancer	0.000208	0.00165	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000207	0.00165	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—CCL2—uterine cancer	0.000205	0.00163	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—EP300—uterine cancer	0.000201	0.0016	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—CTNNB1—uterine cancer	0.000198	0.00158	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SOCS3—uterine cancer	0.000198	0.00158	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—VEGFA—uterine cancer	0.000197	0.00157	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—NRAS—uterine cancer	0.000195	0.00155	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—HRAS—uterine cancer	0.000193	0.00154	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—VEGFA—uterine cancer	0.00019	0.00152	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—SMAD3—uterine cancer	0.00019	0.00152	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CDKN2B—uterine cancer	0.000189	0.00151	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—VEGFA—uterine cancer	0.000189	0.00151	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—NRAS—uterine cancer	0.000188	0.0015	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—NRAS—uterine cancer	0.000187	0.00149	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—EP300—uterine cancer	0.000184	0.00147	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IGF1R—uterine cancer	0.000184	0.00147	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—CXCL8—uterine cancer	0.000183	0.00146	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—ERBB2—uterine cancer	0.000183	0.00146	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—KRAS—uterine cancer	0.000182	0.00145	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—VEGFA—uterine cancer	0.000181	0.00145	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—VEGFA—uterine cancer	0.000181	0.00145	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	0.000181	0.00144	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—NRAS—uterine cancer	0.000179	0.00143	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—NRAS—uterine cancer	0.000179	0.00143	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000178	0.00142	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000178	0.00142	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—HRAS—uterine cancer	0.000176	0.00141	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—ERBB2—uterine cancer	0.000175	0.00139	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—VEGFA—uterine cancer	0.000175	0.00139	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—VEGFA—uterine cancer	0.000175	0.00139	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—VEGFA—uterine cancer	0.000174	0.00139	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SMAD3—uterine cancer	0.000173	0.00138	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—NRAS—uterine cancer	0.000173	0.00138	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—NRAS—uterine cancer	0.000173	0.00138	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—NRAS—uterine cancer	0.000172	0.00137	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000169	0.00135	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—ERBB2—uterine cancer	0.000168	0.00134	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—ERBB2—uterine cancer	0.000168	0.00134	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—KRAS—uterine cancer	0.000168	0.00134	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—CXCL8—uterine cancer	0.000166	0.00132	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—FGFR2—uterine cancer	0.000165	0.00131	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—ERBB2—uterine cancer	0.000162	0.00129	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—ERBB2—uterine cancer	0.000162	0.00129	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—KRAS—uterine cancer	0.000162	0.00129	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—KRAS—uterine cancer	0.000161	0.00128	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—CTNNB1—uterine cancer	0.00016	0.00128	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—ERBB2—uterine cancer	0.00016	0.00127	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	0.000159	0.00127	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MET—uterine cancer	0.000156	0.00124	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—HRAS—uterine cancer	0.000154	0.00123	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—KRAS—uterine cancer	0.000154	0.00123	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—KRAS—uterine cancer	0.000154	0.00123	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—CTNNB1—uterine cancer	0.000153	0.00122	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	0.00015	0.00119	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—EP300—uterine cancer	0.000149	0.00119	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—KRAS—uterine cancer	0.000149	0.00119	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—KRAS—uterine cancer	0.000149	0.00119	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—KRAS—uterine cancer	0.000148	0.00118	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	0.000148	0.00118	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—CTNNB1—uterine cancer	0.000147	0.00117	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—CTNNB1—uterine cancer	0.000147	0.00117	CbGpPWpGaD
Rufinamide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	0.000146	0.00117	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—HRAS—uterine cancer	0.000143	0.00114	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—EP300—uterine cancer	0.000142	0.00113	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—VEGFA—uterine cancer	0.000142	0.00113	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—CTNNB1—uterine cancer	0.000142	0.00113	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—CTNNB1—uterine cancer	0.000142	0.00113	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ESR1—uterine cancer	0.000141	0.00112	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—VEGFA—uterine cancer	0.000141	0.00112	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	0.000139	0.00111	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—NRAS—uterine cancer	0.000139	0.00111	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—HRAS—uterine cancer	0.000138	0.0011	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—EP300—uterine cancer	0.000137	0.00109	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—EP300—uterine cancer	0.000137	0.00109	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—HRAS—uterine cancer	0.000136	0.00109	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—AKT1—uterine cancer	0.000136	0.00109	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	0.000135	0.00108	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—VEGFA—uterine cancer	0.000135	0.00107	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—NRAS—uterine cancer	0.000133	0.00106	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—NRAS—uterine cancer	0.000133	0.00106	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—EP300—uterine cancer	0.000132	0.00105	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—EP300—uterine cancer	0.000132	0.00105	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—HRAS—uterine cancer	0.000131	0.00104	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—HRAS—uterine cancer	0.000131	0.00104	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000131	0.00104	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—VEGFA—uterine cancer	0.000129	0.00103	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—VEGFA—uterine cancer	0.000129	0.00103	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—NRAS—uterine cancer	0.000128	0.00102	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—NRAS—uterine cancer	0.000128	0.00102	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SRD5A2—uterine cancer	0.000127	0.00102	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NDUFB11—uterine cancer	0.000127	0.00102	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—HRAS—uterine cancer	0.000126	0.00101	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—HRAS—uterine cancer	0.000126	0.00101	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—HRAS—uterine cancer	0.000126	0.001	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TP53—uterine cancer	0.000125	0.000998	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—VEGFA—uterine cancer	0.000125	0.000995	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—VEGFA—uterine cancer	0.000125	0.000995	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CCL2—uterine cancer	0.000124	0.00099	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—NRAS—uterine cancer	0.000123	0.000983	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—NRAS—uterine cancer	0.000123	0.000983	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—VEGFA—uterine cancer	0.000123	0.00098	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—AKT1—uterine cancer	0.000122	0.000969	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—NRAS—uterine cancer	0.000121	0.000968	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—KRAS—uterine cancer	0.00012	0.000955	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—PIK3CA—uterine cancer	0.000116	0.000925	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—KRAS—uterine cancer	0.000115	0.000915	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—KRAS—uterine cancer	0.000115	0.000913	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—ERBB2—uterine cancer	0.000114	0.000908	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—AKT1—uterine cancer	0.000111	0.000886	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	0.00011	0.000877	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—KRAS—uterine cancer	0.00011	0.000877	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—KRAS—uterine cancer	0.00011	0.000877	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IRF1—uterine cancer	0.00011	0.000875	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SRD5A2—uterine cancer	0.00011	0.000873	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NDUFB11—uterine cancer	0.00011	0.000873	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	0.000109	0.000865	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000106	0.000848	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—KRAS—uterine cancer	0.000106	0.000846	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—KRAS—uterine cancer	0.000106	0.000846	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—PIK3CA—uterine cancer	0.000105	0.00084	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—KRAS—uterine cancer	0.000105	0.000833	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ERBB2—uterine cancer	0.000104	0.000825	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—HRAS—uterine cancer	0.000102	0.000811	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000101	0.000801	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—CTNNB1—uterine cancer	9.97e-05	0.000795	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CXCL8—uterine cancer	9.82e-05	0.000782	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—HRAS—uterine cancer	9.75e-05	0.000777	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—HRAS—uterine cancer	9.74e-05	0.000776	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CDKN1B—uterine cancer	9.59e-05	0.000764	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—AKT1—uterine cancer	9.48e-05	0.000756	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—HRAS—uterine cancer	9.36e-05	0.000746	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—HRAS—uterine cancer	9.36e-05	0.000746	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—EP300—uterine cancer	9.27e-05	0.000739	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—STAR—uterine cancer	9.22e-05	0.000735	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKR1B1—uterine cancer	9.22e-05	0.000735	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CTNNB1—uterine cancer	9.06e-05	0.000722	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—HRAS—uterine cancer	9.02e-05	0.000719	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—HRAS—uterine cancer	9.02e-05	0.000719	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—AKT1—uterine cancer	8.99e-05	0.000716	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—HRAS—uterine cancer	8.89e-05	0.000708	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PTEN—uterine cancer	8.83e-05	0.000704	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—VEGFA—uterine cancer	8.78e-05	0.000699	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—NRAS—uterine cancer	8.67e-05	0.000691	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—AKT1—uterine cancer	8.61e-05	0.000686	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—AKT1—uterine cancer	8.6e-05	0.000685	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EP300—uterine cancer	8.42e-05	0.000671	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—AKT1—uterine cancer	8.26e-05	0.000658	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—AKT1—uterine cancer	8.26e-05	0.000658	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VEGFA—uterine cancer	7.97e-05	0.000635	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—AKT1—uterine cancer	7.97e-05	0.000635	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—AKT1—uterine cancer	7.97e-05	0.000635	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKR1B1—uterine cancer	7.92e-05	0.000631	CbGpPWpGaD
Rufinamide—ALB—Metabolism—STAR—uterine cancer	7.92e-05	0.000631	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NRAS—uterine cancer	7.88e-05	0.000628	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	7.83e-05	0.000624	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—KRAS—uterine cancer	7.46e-05	0.000595	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—POLD1—uterine cancer	7.23e-05	0.000576	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—KRAS—uterine cancer	6.78e-05	0.00054	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKR1C1—uterine cancer	6.76e-05	0.000539	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—HRAS—uterine cancer	6.34e-05	0.000505	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	6.3e-05	0.000502	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CA—uterine cancer	6.23e-05	0.000496	CbGpPWpGaD
Rufinamide—ALB—Metabolism—POLD1—uterine cancer	6.22e-05	0.000495	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—RRM2—uterine cancer	6.03e-05	0.000481	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TP53—uterine cancer	6.02e-05	0.00048	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NDUFB11—uterine cancer	5.91e-05	0.000471	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SRD5A2—uterine cancer	5.91e-05	0.000471	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—DCN—uterine cancer	5.85e-05	0.000466	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKR1C1—uterine cancer	5.81e-05	0.000463	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HRAS—uterine cancer	5.76e-05	0.000459	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—AKT1—uterine cancer	5.6e-05	0.000446	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP11A1—uterine cancer	5.51e-05	0.00044	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKR1C3—uterine cancer	5.21e-05	0.000415	CbGpPWpGaD
Rufinamide—ALB—Metabolism—RRM2—uterine cancer	5.18e-05	0.000413	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—AKT1—uterine cancer	5.09e-05	0.000405	CbGpPWpGaD
Rufinamide—ALB—Metabolism—DCN—uterine cancer	5.03e-05	0.000401	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	4.92e-05	0.000392	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP11A1—uterine cancer	4.74e-05	0.000378	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKR1C3—uterine cancer	4.48e-05	0.000357	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKR1B1—uterine cancer	4.28e-05	0.000341	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—STAR—uterine cancer	4.28e-05	0.000341	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—STK11—uterine cancer	4.06e-05	0.000323	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP19A1—uterine cancer	4.06e-05	0.000323	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	4.02e-05	0.00032	CbGpPWpGaD
Rufinamide—ALB—Metabolism—STK11—uterine cancer	3.49e-05	0.000278	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP19A1—uterine cancer	3.49e-05	0.000278	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—EP300—uterine cancer	3.43e-05	0.000273	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—POLD1—uterine cancer	3.36e-05	0.000267	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.27e-05	0.000261	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFA—uterine cancer	3.25e-05	0.000259	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NRAS—uterine cancer	3.21e-05	0.000256	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKR1C1—uterine cancer	3.14e-05	0.00025	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.12e-05	0.000249	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MTHFR—uterine cancer	3.05e-05	0.000243	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—RRM2—uterine cancer	2.8e-05	0.000223	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—KRAS—uterine cancer	2.76e-05	0.00022	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—DCN—uterine cancer	2.72e-05	0.000216	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MTHFR—uterine cancer	2.62e-05	0.000209	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.56e-05	0.000204	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CA—uterine cancer	2.54e-05	0.000202	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TP53—uterine cancer	2.45e-05	0.000196	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.42e-05	0.000193	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HRAS—uterine cancer	2.35e-05	0.000187	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.31e-05	0.000184	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT1—uterine cancer	2.07e-05	0.000165	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—STK11—uterine cancer	1.88e-05	0.00015	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.88e-05	0.00015	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTEN—uterine cancer	1.7e-05	0.000135	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—EP300—uterine cancer	1.62e-05	0.000129	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTEN—uterine cancer	1.46e-05	0.000116	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTHFR—uterine cancer	1.41e-05	0.000113	CbGpPWpGaD
Rufinamide—ALB—Metabolism—EP300—uterine cancer	1.39e-05	0.000111	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CA—uterine cancer	1.2e-05	9.54e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CA—uterine cancer	1.03e-05	8.2e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKT1—uterine cancer	9.78e-06	7.79e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKT1—uterine cancer	8.4e-06	6.7e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTEN—uterine cancer	7.87e-06	6.27e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—EP300—uterine cancer	7.5e-06	5.98e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CA—uterine cancer	5.55e-06	4.42e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKT1—uterine cancer	4.54e-06	3.61e-05	CbGpPWpGaD
